Grifols continues to lead initiatives to combat COVID-19 with the development of the first specific drug
- Grifols has become the first company to start production of an anti-SARS-CoV-2 hyperimmune immunoglobulin by leveraging its broad expertise and experience in the development of specific immunoglobulins used in the treatment and prevention of infections and that have been applied to healthcare emergencies like the Ebola outbreak
- Grifols is a worldwide leader in the production and sale of immunoglobulins, a plasma protein with proven safety, broad clinical applications and significant therapeutic potential Read More...
2014-10-23T16:07:00Z Maverick Capital is launching a $50 million venture-capital fund, joining a growing number of Wall Street firms that are cashing in on Silicon Valley.
The Wall Street Journal's Juliet Chung reports that Maverick's fund will focus on companies in the software, healthcare and consumer industries.
It launches on January 1.
Maverick Capital is helmed by Lee Ainslie. The fund has returned 12% since its founding in 1995. The S&P 500 has returned 9. Read More...
